Hemophilia is a congenital bleeding disorder caused by the deficiency of certain clotting proteins in the blood. The most common type, Hemophilia A, accounts for 80% of cases and is due to a deficiency of clotting factor VIII. The second type, Hemophilia B (also known as Christmas Disease), is caused by a deficiency of factor IX.

Hemophilia is a complex disorder that can lead to significant health challenges and requires lifelong treatment. In severe cases, individuals may experience repeated bleeding into their joints, which can cause chronic joint disease, joint pain, reduced mobility, and musculoskeletal deformities. This can severely impact their quality of life, affecting education, employment, and other social aspects.

Proper management of Hemophilia is essential to preventing long-term complications and minimizing treatment costs. According to the World Health Organization (WHO), Hemophilia affects about 1 in every 10,000 births.